Cargando…

Effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of cardiovascular disease: protocol for an overview of systematic reviews

INTRODUCTION: Major clinical practice guidelines recommend assessing risk of cardiovascular disease (CVD) using absolute/global/total CVD risk scores. However, the effectiveness of using them in clinical practice, despite publication of numerous randomised controlled trials (RCTs), is still poorly u...

Descripción completa

Detalles Bibliográficos
Autores principales: Studzin´ski, Krzysztof, Tomasik, Tomasz, Krzyszton´, Janusz, Józ´wiak, Jacek, Windak, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353260/
https://www.ncbi.nlm.nih.gov/pubmed/28274967
http://dx.doi.org/10.1136/bmjopen-2016-014206
_version_ 1782515072499712000
author Studzin´ski, Krzysztof
Tomasik, Tomasz
Krzyszton´, Janusz
Józ´wiak, Jacek
Windak, Adam
author_facet Studzin´ski, Krzysztof
Tomasik, Tomasz
Krzyszton´, Janusz
Józ´wiak, Jacek
Windak, Adam
author_sort Studzin´ski, Krzysztof
collection PubMed
description INTRODUCTION: Major clinical practice guidelines recommend assessing risk of cardiovascular disease (CVD) using absolute/global/total CVD risk scores. However, the effectiveness of using them in clinical practice, despite publication of numerous randomised controlled trials (RCTs), is still poorly understood. To summarise and analyse current knowledge in this field, we will carry out an overview of existing systematic reviews (SRs). The objective of this overview will be to assess the effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of CVD compared with standard care. METHODS AND ANALYSIS: We will include SRs and meta-analyses which take into account RCTs and quasi-RCTs investigating the effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of CVD. SRs will be retrieved from 4 bibliographical databases and reference lists of identified reviews. Additionally, the PROSPERO database will be searched for unpublished, ongoing or recently completed SRs. 2 reviewers will assess the SRs independently for eligibility and bias. The data will be extracted to a special form. Any disagreement will be resolved by discussion. In case of lack of consensus, a third author will arbitrate. The overview of SRs will be reported according to the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) statement. ETHICS AND DISSEMINATION: Ethics approval is not required for overview of SRs. We will summarise evidence concerning whether use of the absolute/global/total CVD risk scoring tools in primary prevention of CVD is effective and supported with scientific data or not. If we face unsatisfactory confirmation, we will highlight a need for further research and advice on how to plan such a study. We will submit the results of our study for peer-review publication in a journal indexed in the international bibliographic database of biomedical information.
format Online
Article
Text
id pubmed-5353260
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-53532602017-03-17 Effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of cardiovascular disease: protocol for an overview of systematic reviews Studzin´ski, Krzysztof Tomasik, Tomasz Krzyszton´, Janusz Józ´wiak, Jacek Windak, Adam BMJ Open Cardiovascular Medicine INTRODUCTION: Major clinical practice guidelines recommend assessing risk of cardiovascular disease (CVD) using absolute/global/total CVD risk scores. However, the effectiveness of using them in clinical practice, despite publication of numerous randomised controlled trials (RCTs), is still poorly understood. To summarise and analyse current knowledge in this field, we will carry out an overview of existing systematic reviews (SRs). The objective of this overview will be to assess the effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of CVD compared with standard care. METHODS AND ANALYSIS: We will include SRs and meta-analyses which take into account RCTs and quasi-RCTs investigating the effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of CVD. SRs will be retrieved from 4 bibliographical databases and reference lists of identified reviews. Additionally, the PROSPERO database will be searched for unpublished, ongoing or recently completed SRs. 2 reviewers will assess the SRs independently for eligibility and bias. The data will be extracted to a special form. Any disagreement will be resolved by discussion. In case of lack of consensus, a third author will arbitrate. The overview of SRs will be reported according to the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) statement. ETHICS AND DISSEMINATION: Ethics approval is not required for overview of SRs. We will summarise evidence concerning whether use of the absolute/global/total CVD risk scoring tools in primary prevention of CVD is effective and supported with scientific data or not. If we face unsatisfactory confirmation, we will highlight a need for further research and advice on how to plan such a study. We will submit the results of our study for peer-review publication in a journal indexed in the international bibliographic database of biomedical information. BMJ Publishing Group 2017-03-08 /pmc/articles/PMC5353260/ /pubmed/28274967 http://dx.doi.org/10.1136/bmjopen-2016-014206 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Cardiovascular Medicine
Studzin´ski, Krzysztof
Tomasik, Tomasz
Krzyszton´, Janusz
Józ´wiak, Jacek
Windak, Adam
Effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of cardiovascular disease: protocol for an overview of systematic reviews
title Effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of cardiovascular disease: protocol for an overview of systematic reviews
title_full Effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of cardiovascular disease: protocol for an overview of systematic reviews
title_fullStr Effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of cardiovascular disease: protocol for an overview of systematic reviews
title_full_unstemmed Effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of cardiovascular disease: protocol for an overview of systematic reviews
title_short Effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of cardiovascular disease: protocol for an overview of systematic reviews
title_sort effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of cardiovascular disease: protocol for an overview of systematic reviews
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353260/
https://www.ncbi.nlm.nih.gov/pubmed/28274967
http://dx.doi.org/10.1136/bmjopen-2016-014206
work_keys_str_mv AT studzinskikrzysztof effectofusingcardiovascularriskscoringinroutineriskassessmentinprimarypreventionofcardiovasculardiseaseprotocolforanoverviewofsystematicreviews
AT tomasiktomasz effectofusingcardiovascularriskscoringinroutineriskassessmentinprimarypreventionofcardiovasculardiseaseprotocolforanoverviewofsystematicreviews
AT krzysztonjanusz effectofusingcardiovascularriskscoringinroutineriskassessmentinprimarypreventionofcardiovasculardiseaseprotocolforanoverviewofsystematicreviews
AT jozwiakjacek effectofusingcardiovascularriskscoringinroutineriskassessmentinprimarypreventionofcardiovasculardiseaseprotocolforanoverviewofsystematicreviews
AT windakadam effectofusingcardiovascularriskscoringinroutineriskassessmentinprimarypreventionofcardiovasculardiseaseprotocolforanoverviewofsystematicreviews